TickerFacts.

Vaso Corp (VASO): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2019-12-31, 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$29.43M
As of 2025-12-31
$29.21M
As of 2026-06-30
+10.1%
3-year compound annual growth
2011-05-31: $2.91M2011-12-31: $11.28M2012-12-31: $9.01M2013-12-31: $6.46M2014-12-31: $7.75M2015-12-31: $11.74M2016-12-31: $12.91M2017-12-31: $9.15M2018-12-31: $5.61M2019-12-31: $4.31M2020-12-31: $5.08M2021-12-31: $11.31M2022-12-31: $22.07M2023-12-31: $26.84M2024-12-31: $27.70M2025-12-31: $29.43M$29.43M
2011-05-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$29.43M+6.2%2026-03-31, Balance as of period end
2024-12-31$27.70M+3.2%2026-03-31, Balance as of period end
2023-12-31$26.84M+21.6%2025-03-31, Balance as of period end
2022-12-31$22.07Mn/c2024-04-01, Balance as of period end
2021-12-31$11.31M+122.4%2023-03-31, Balance as of period end
2020-12-31$5.08M+17.9%2022-03-31, Balance as of period end
2019-12-31$4.31Mn/c2021-05-05, Balance as of period end
2018-12-31$5.61M-38.7%2020-04-14, Balance as of period end
2017-12-31$9.15M-29.1%2019-04-15, Balance as of period end
2016-12-31$12.91M+10.0%2018-04-02, Balance as of period end
2015-12-31$11.74M+51.5%2017-03-30, Balance as of period end
2014-12-31$7.75M+19.9%2016-03-30, Balance as of period end
2013-12-31$6.46M-28.2%2015-03-30, Balance as of period end
2012-12-31$9.01M-20.1%2014-03-27, Balance as of period end
2011-12-31$11.28Mn/a2014-03-27, Balance as of period end
2011-05-31$2.91Mn/a2013-04-01, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Vaso Corp (VASO)2025-12-31$29.43M+6.2%
Ceribell, Inc. (CBLL)2025-12-31$155.34M-18.7%
Biolife Solutions Inc (BLFS)2025-12-31$371.89M+6.6%
Electromed, Inc. (ELMD)2026-06-30$53.98M+24.9%
Outset Medical, Inc. (OM)2025-12-31$126.95M+373.4%
Iridex Corp (IRIX)2026-01-03$4.92M+134.7%
Axogen, Inc. (AXGN)2025-12-31$128.85M+24.0%
Stereotaxis, Inc. (STXS)2025-12-31$13.48M+121.7%
electroCore, Inc. (ECOR)2025-12-31-$1.71Mn/m

Compare VASO, CBLL, BLFS, ELMD side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗